The global stocks were higher amid positive data from AstraZeneca
The US
AstraZeneca's effect seems to linger over the markets. Moreover, the President-elect Joe Biden is looking to nominate a former Federal Reserve Chair as Treasury Secretary boosted the momentum. USA30 rose 1.13%, while USA500 went up 0.61%. TECH100 added 0.22%.
Gold settled at $1,835 per ounce after, during intraday trading, it reached a low of $1,828.25 – a level unseen since July 17.
Crude Oil settled up 1.9% at $43.25 per barrel.
The Dollar Index closed the day at 92.264.
Asia and Australia
The stocks traded mixedly at the beginning of the week, some focusing on the pharma companies' progress towards a viable COVID-19 vaccine. Others focused on the rising number of infections.
HongKong45 went down 0.14% as it is battling a new wave of COVID-19 infections.
Down under, Australia200 gained 0.53% as the country eased some COVID-19 restrictions.
Europe
AstraZeneca seems to be on everyone's lips, as it made Europe50 gain 0.5% - the most significant increase the benchmark had since February. Germany30 went up 1%, while France40 ended 0.8% higher. UK100 inched up 0.3%.
Brent Oil rose 1.5% to $45.75 per barrel.
EUR/USD settled at 1.1874 after it added 0.2%.
Sources: reuters.com, investing.com
Users/readers should not rely solely on the information presented herewith and should do their own research/analysis by also reading the actual underlying research. The content herewith is generic and does not take into consideration individual personal circumstances, investment experience or current financial situation.
Therefore, Key Way Investments Ltd shall not accept any responsibility for any losses of traders due to the use and the content of the information presented herein. Past performance and forecasts are not reliable indicators of future results.
